WWM
AMPE

Western Wealth Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Western Wealth Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-75
Closed -$1K – 871
2022
Q1 		$1K Buy
+75
New +$11K ﹤0.01% 821
2021
Q1 		– Sell
-135
Closed -$16K – 548
2020
Q4 		$16K Buy
135
+134
+13,400% +$44K ﹤0.01% 464
2020
Q3 		$15K Sell
1
-132
-99% -$32.7K ﹤0.01% 440
2020
Q2 		$13K Buy
+133
New +$22.1K ﹤0.01% 422
2019
Q4 		– Sell
-268
Closed -$10K – 429
2019
Q3 		$10K Buy
+268
New +$35.7K ﹤0.01% 387

Other funds holding AMPE

CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
JWM
Janiczek Wealth Management Denver, Colorado $477M AUM 15.17% 1-Year Est. Return

Western Wealth Management's AMPE Position: Q3 2023 in Review

Western Wealth Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2023, closing a stake of 1,224 shares — an estimated $5.7K sold.

Western Wealth Management first reported a position in AMPE in Q3 2019 and held it in 13 quarters. The position peaked at $1.7M in Q1 2021. 26 funds tracked by Wall St. Rank hold AMPE as of Q3 2023.

  • Western Wealth Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2023 after selling out during the quarter.
  • Western Wealth Management sold 1,224 Ampio Pharmaceuticals Inc. shares in Q3 2023, an estimated $5.7K.
  • Western Wealth Management first reported a position in Ampio Pharmaceuticals Inc. in Q3 2019 and held it in 13 quarters.
  • Western Wealth Management's Ampio Pharmaceuticals Inc. position peaked at $1.7M in Q1 2021.
  • 26 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2023.

Based on Western Wealth Management's 13F filing for Q3 2023, filed 8 Nov 2023.